-
-
-
-
-
-
-
Entrada Therapeutics, Inc. (TRDA) Tops Q1 EPS by 31c
-
-
-
-
-
-
-
Entrada Therapeutics Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Entrada Therapeutics Reports First Quarter 2023 Financial Results
-
-
-
-
-
-
-
Entrada Therapeutics (TRDA) Reports Q1 Net Loss of $21.7M
-
-
-
-
-
-
-
Entrada Therapeutics Reports Third Quarter 2021 Financial Results
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

